Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - sumatriptan succinate, quantity: 140 mg - tablet - excipient ingredients: lactose; croscarmellose sodium; colloidal anhydrous silica; microcrystalline cellulose; crospovidone; magnesium stearate; titanium dioxide; hypromellose; macrogol 400 - sumatriptan tablets are indicated for the acute relief of migraine attacks with or without aura. there is no information available on the use of sumatriptan tablets in the treatment of basilar or hemiplegic migraine.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - sumatriptan succinate, quantity: 140 mg - tablet - excipient ingredients: croscarmellose sodium; lactose; magnesium stearate; crospovidone; colloidal anhydrous silica; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 400 - sumatriptan tablets are indicated for the acute relief of migraine attacks with or without aura. there is no information available on the use of sumatriptan tablets in the treatment of basilar or hemiplegic migraine.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - sumatriptan succinate, quantity: 140 mg - tablet - excipient ingredients: croscarmellose sodium; microcrystalline cellulose; lactose; magnesium stearate; colloidal anhydrous silica; crospovidone; titanium dioxide; hypromellose; macrogol 400 - sumatriptan tablets are indicated for the acute relief of migraine attacks with or without aura. there is no information available on the use of sumatriptan tablets in the treatment of basilar or hemiplegic migraine.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sumatriptan succinate, quantity: 70 mg - tablet - excipient ingredients: magnesium stearate; colloidal anhydrous silica; lactose; microcrystalline cellulose; crospovidone; croscarmellose sodium; titanium dioxide; hypromellose; iron oxide red; iron oxide black; macrogol 400 - sumatriptan tablets are indicated for the acute relief of migraine attacks with or without aura. there is no information available on the use of sumatriptan tablets in the treatment of basilar or hemiplegic migraine.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - sumatriptan succinate, quantity: 70 mg - tablet - excipient ingredients: lactose; croscarmellose sodium; colloidal anhydrous silica; microcrystalline cellulose; crospovidone; magnesium stearate; titanium dioxide; hypromellose; iron oxide red; iron oxide black; macrogol 400 - sumatriptan tablets are indicated for the acute relief of migraine attacks with or without aura. there is no information available on the use of sumatriptan tablets in the treatment of basilar or hemiplegic migraine.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - sumatriptan succinate, quantity: 70 mg - tablet - excipient ingredients: microcrystalline cellulose; crospovidone; lactose; croscarmellose sodium; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; iron oxide red; iron oxide black; macrogol 400 - sumatriptan tablets are indicated for the acute relief of migraine attacks with or without aura. there is no information available on the use of sumatriptan tablets in the treatment of basilar or hemiplegic migraine.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - sumatriptan succinate, quantity: 70 mg - tablet - excipient ingredients: magnesium stearate; microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; crospovidone; lactose; titanium dioxide; hypromellose; iron oxide red; iron oxide black; macrogol 400 - sumatriptan tablets are indicated for the acute relief of migraine attacks with or without aura. there is no information available on the use of sumatriptan tablets in the treatment of basilar or hemiplegic migraine.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - sumatriptan succinate, quantity: 139.98 mg - tablet, film coated - excipient ingredients: lactose monohydrate; hypromellose; croscarmellose sodium; magnesium stearate; microcrystalline cellulose; titanium dioxide - pharmacor sumatriptan is indicated for the acute relief of migraine attacks with or without aura.,there is no information available on the use of sumatriptan tablets in the treatment of basilar or hemiplegic migraine

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - sumatriptan succinate, quantity: 69.99 mg - tablet, film coated - excipient ingredients: hypromellose; magnesium stearate; croscarmellose sodium; microcrystalline cellulose; lactose monohydrate; titanium dioxide; triacetin; iron oxide red - pharmacor sumatriptan is indicated for the acute relief of migraine attacks with or without aura.,there is no information available on the use of sumatriptan tablets in the treatment of basilar or hemiplegic migraine

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - sumatriptan succinate, quantity: 140 mg (equivalent: sumatriptan, qty 100 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; lactose monohydrate; magnesium stearate; titanium dioxide; hypromellose; macrogol 8000; triacetin; polydextrose - iptam tablets are indicated for the acute relief of migraine attacks with or without aura. there is no information available on the use of iptam in the treatment of basilar or hemiplegic migraines.